Quercetin bioavailability is associated with inadequate plasma vitamin C status and greater plasma endotoxin in adults

Nutrition

Volumn 30, Issue 11-12, 2014, Pages 1279-1286

  Guo, Yi ^a,b   Mah, Eunice ^a   Bruno, Richard S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Endotoxin; Interindividual variability; Pharmacokinetics; Quercetin; Vitamin C

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; CAROTENOID; DRUG METABOLITE; ENDOTOXIN; GAMMA TOCOPHEROL; ISORHAMNETIN; MALONALDEHYDE; MYELOPEROXIDASE; QUERCETIN; TAMARIXETIN; UNCLASSIFIED DRUG; URIC ACID; 3-METHYLQUERCETIN; ANTIOXIDANT; DISACCHARIDE; PEROXIDASE;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; ELIMINATION HALF-LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; OXIDATIVE STRESS; TIME TO MAXIMUM PLASMA CONCENTRATION; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BIOAVAILABILITY; BLOOD; INTESTINE ABSORPTION; METABOLISM;

ADULT; ANTIOXIDANTS; AREA UNDER CURVE; ASCORBIC ACID; BIOLOGICAL AVAILABILITY; C-REACTIVE PROTEIN; DISACCHARIDES; ENDOTOXINS; FEMALE; HUMANS; INFLAMMATION; INTESTINAL ABSORPTION; MALE; OXIDATIVE STRESS; PEROXIDASE; QUERCETIN;

EID: 84908135754     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.03.032     Document Type: Article

References (53)

1. Harnly J.M., Doherty R.F., Beecher G.R., Holden J.M., Haytowitz D.B., Bhagwat S., et al. Flavonoid content of U.S. fruits, vegetables, and nuts. J Agric Food Chem 2006, 54:9966-9977.
2. Hubbard G.P., Wolffram S., de Vos R., Bovy A., Gibbins J.M., Lovegrove J.A. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: A pilot study. Br J Nutr 2006, 96:482-488.
3. Knab A.M., Shanely R.A., Henson D.A., Jin F., Heinz S.A., Austin M.D., et al. Influence of quercetin supplementation on disease risk factors in community-dwelling adults. J Am Diet Assoc 2011, 111:542-549.
4. Kaushik D., O'Fallon K., Clarkson P.M., Dunne C.P., Conca K.R., Michniak-Kohn B. Comparison of quercetin pharmacokinetics following oral supplementation in humans. J Food Sci 2012, 77:H231-H238.
5. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002, 11:1025-1032.
6. Milbury P.E., Vita J.A., Blumberg J.B. Anthocyanins are bioavailable in humans following an acute dose of cranberry juice. J Nutr 2010, 140:1099-1104.
7. Graefe E.U., Wittig J., Mueller S., Riethling A.K., Uehleke B., Drewelow B., et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. JClin Pharmacol 2001, 41:492-499.
8. Egert S., Wolffram S., Bosy-Westphal A., Boesch-Saadatmandi C., Wagner A.E., Frank J., et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008, 138:1615-1621.
9. Moon Y.J., Wang L., DiCenzo R., Morris M.E. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 2008, 29:205-217.
10. Jin F., Nieman D.C., Shanely R.A., Knab A.M., Austin M.D., Sha W. The variable plasma quercetin response to 12-wk quercetin supplementation in humans. Eur J Clin Nutr 2010, 64:692-697.
11. Del Rio D., Rodriguez-Mateos A., Spencer J.P., Tognolini M., Borges G., Crozier A. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013, 18:1818-1892.
12. Lampe J.W., Chang J.L. Interindividual differences in phytochemical metabolism and disposition. Semin Cancer Biol 2007, 17:347-353.
13. Pietta P.G. Flavonoids as antioxidants. J Nat Prod 2000, 63:1035-1042.
14. Buettner G.R. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 1993, 300:535-543.
15. Jovanovic S.V., Steenken S., Hara Y., Simic M.G. Reduction potentials of flavonoid and model phenoxyl radicals. Which ring in flavonoids is responsible for antioxidant activity?. J Chem Soc, Perkin Trans 2 1996, 11:2497-2504.
16. Boots A.W., Kubben N., Haenen G.R., Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: Implication for quercetin supplementation. Biochem Biophys Res Commun 2003, 308:560-565.
17. Nait Chabane M., Al Ahmad A., Peluso J., Muller C.D., Ubeaud G. Quercetin and naringenin transport across human intestinal Caco-2 cells. J Pharm Pharmacol 2009, 61:1473-1483.
18. John L.J., Fromm M., Schulzke J.D. Epithelial barriers in intestinal inflammation. Antioxid Redox Signal 2011, 15:1255-1270.
19. Guo Y., Mah E., Davis C.G., Jalili T., Ferruzzi M.G., Chun O.K., et al. Dietary fat increases quercetin bioavailability in overweight adults. Mol Nutr Food Res 2013, 57:896-905.
20. Nemeth K., Plumb G.W., Berrin J.G., Juge N., Jacob R., Naim H.Y., et al. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 2003, 42:29-42.
21. Bruno R.S., Dugan C.E., Smyth J.A., DiNatale D.A., Koo S.I. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 2008, 138:323-331.
22. Kunces L.J., Cusack L.K., Kupchak B.R., Volk B.M., Freidenreich D.J., Aristizabal J.C., et al. Triacylglycerol recrystallized phytosterols in fat-free milk improve lipoprotein profiles more than unmodified free phytosterols in hypercholesterolemic men and women. J Am Coll Nutr 2013, 32:234-242.
23. Mah E., Noh S.K., Ballard K.D., Matos M.E., Volek J.S., Bruno R.S. Postprandial hyperglycemia impairs vascular endothelial function in healthy men by inducing lipid peroxidation and increasing asymmetrical dimethylarginine:arginine. J Nutr 2011, 141:1961-1968.
24. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
25. Lin J., Zhang S.M., Wu K., Willett W.C., Fuchs C.S., Giovannucci E. Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 2006, 164:644-651.
26. Manach C., Morand C., Demigne C., Texier O., Regerat F., Remesy C. Bioavailability of rutin and quercetin in rats. FEBS Lett 1997, 409:12-16.
27. Schleicher R.L., Carroll M.D., Ford E.S., Lacher D.A. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003 to 2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr 2009, 90:1252-1263.
28. Ghanim H., Sia C.L., Upadhyay M., Korzeniewski K., Viswanathan P., Abuaysheh S., et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr 2010, 91:940-949.
29. Ashton T., Young I.S., Davison G.W., Rowlands C.C., McEneny J., Van Blerk C., et al. Exercise-induced endotoxemia: The effect of ascorbic acid supplementation. Free Radic Biol Med 2003, 35:284-291.
30. Akyildiz M., Ersin S., Oymaci E., Dayangac M., Kapkac M., Alkanat M. Effects of somatostatin analogs and vitamin C on bacterial translocation in an experimental intestinal obstruction model of rats. J Invest Surg 2000, 13:169-173.
31. Tabak M., Armon R., Rosenblat G., Stermer E., Neeman I. Diverse effects of ascorbic acid and palmitoyl ascorbate on Helicobacter pylori survival and growth. FEMS Microbiol Lett 2003, 224:247-253.
32. Dwenger A., Funck M., Lueken B., Schweitzer G., Lehmann U. Effect of ascorbic acid on neutrophil functions and hypoxanthine/xanthine oxidase-generated, oxygen-derived radicals. Eur J Clin Chem Clin Biochem 1992, 30:187-191.
33. Mah E., Matos M.D., Kawiecki D., Ballard K., Guo Y., Volek J.S., et al. Vitamin C status is related to proinflammatory responses and impaired vascular endothelial function in healthy, college-aged lean and obese men. J Am Diet Assoc 2011, 111:737-743.
34. Ammori B.J., Becker K.L., Kite P., Snider R.H., Nylen E.S., White J.C., et al. Calcitonin precursors: Early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas 2003, 27:239-243.
35. Lee J., Mitchell A.E. Pharmacokinetics of quercetin absorption from apples and onions in healthy humans. J Agric Food Chem 2012, 60:3874-3881.
36. Khoo N.K., White C.R., Pozzo-Miller L., Zhou F., Constance C., Inoue T., et al. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med 2010, 49:339-347.
37. Edwards R.L., Lyon T., Litwin S.E., Rabovsky A., Symons J.D., Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007, 137:2405-2411.
38. Egert S., Bosy-Westphal A., Seiberl J., Kurbitz C., Settler U., Plachta-Danielzik S., et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled crossover study. Br J Nutr 2009, 102:1065-1074.
39. Shanely R.A., Knab A.M., Nieman D.C., Jin F., McAnulty S.R., Landram M.J. Quercetin supplementation does not alter antioxidant status in humans. Free Radic Res 2010, 44:224-231.
40. Brun P., Castagliuolo I., Di Leo V., Buda A., Pinzani M., Palu G., et al. Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007, 292:G518-G525.
41. Moreno-Navarrete J.M., Sabater M., Ortega F., Ricart W., Fernandez-Real J.M. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One 2012, 7:e37160.
42. Guo Y., Bruno R.S. Vasoprotective activities of quercetin. Agro Food Ind Hi Tec 2011, 22:17-19.
43. Ameho C.K., Chen C.Y., Smith D., Sanchez-Moreno C., Milbury P.E., Blumberg J.B. Antioxidant activity and metabolite profile of quercetin in vitamin-E-depleted rats. J Nutr Biochem 2008, 19:467-474.
44. Frank J., Budek A., Lundh T., Parker R.S., Swanson J.E., Lourenco C.F., et al. Dietary flavonoids with a catechol structure increase alpha-tocopherol in rats and protect the vitamin from oxidation invitro. J Lipid Res 2006, 47:2718-2725.
45. Takahama U., Yamamoto A., Hirota S., Oniki T. Quercetin-dependent reduction of salivary nitrite to nitric oxide under acidic conditions and interaction between quercetin and ascorbic acid during the reduction. J Agric Food Chem 2003, 51:6014-6020.
46. Skaper S.D., Fabris M., Ferrari V., Dalle Carbonare M., Leon A. Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: Cooperative effects of ascorbic acid. Free Radic Biol Med 1997, 22:669-678.
47. Gey K.F., Moser U.K., Jordan P., Stahelin H.B., Eichholzer M., Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiologic update with special attention to carotene and vitamin C. Am J Clin Nutr 1993, 57:787S-797S.
48. Bock K.W. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): Mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol 2010, 80:771-777.
49. Boersma M.G., van der Woude H., Bogaards J., Boeren S., Vervoort J., Cnubben N.H., et al. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 2002, 15:662-670.
50. Stingl J.C., Bartels H., Viviani R., Lehmann M.L., Brockmoller J. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review. Pharmacol Ther 2014, 141:92-116.
51. Kalitsky-Szirtes J., Shayeganpour A., Brocks D.R., Piquette-Miller M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab Dispos 2004, 32:20-27.
52. Oudemans-van Straaten H.M., Jansen P.G., Hoek F.J., van Deventer S.J., Sturk A., Stoutenbeek C.P., et al. Intestinal permeability, circulating endotoxin, andpostoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 1996, 10:187-194.
53. Teshima C.W., Meddings J.B. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep 2008, 10:443-449.